See if You Qualify for
Stem Cell Therapy
Request
FREE CONSULTATION

    See our privacy policy

     
   

Organizations that
Charles H. Newcomer
Dr. Ernesto Gutierrez
Are members of

icms

Organizations

Stem Cell Therapy for Lupus

Lupus


Systemic lupus erythermatosus, often abbreviated to SLE or lupus, is a chronic systemic autoimmune disease (or autoimmune connective tissue disease) that can affect any part of the body. As occurs in other autoimmune diseases, the immune system attacks the body’s cells and tissue, resulting in inflammation and tissue damage.[2] SLE most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system. The course of the disease is unpredictable, with periods of illness (called flares) alternating with remissions. The disease occurs nine times more often in women than in men, especially women in child-bearing years ages 15 to 35, and is more common in those of non-European descent.[3] [4] [5]

In SLE, the body’s immune system produces antibodies against itself, particularly against proteins in the cell nucleus. SLE is triggered by environmental factors that are unknown.

“All the key components of the immune system are involved in the underlying mechanisms [of SLE]” according to Rahman, and SLE is the prototypical autoimmune disease. The immune system must have a balance (homeostasis) between being sensitive enough to protect against infection, and being too sensitive and attacking the bodies own proteins (autoimmunity). From an evolutionary perspective, according to Crow, the population must have enough genetic diversity to protect itself against a wide range of possible infection; some genetic combinations result in autoimmunity. The likely environmental triggers include ultraviolet light, drugs, and viruses. These stimuli cause the destruction of cells and expose their DNA, histones, and other proteins, particularly parts of the cell nucleus. Because of genetic variations in different components of the immune system, in some people the immune system attacks these nuclear-related proteins and produces antibodies against them. In the end, these antibody complexes damage blood vessels in critical areas of the body, such as the glomeruli of the kidney; these antibody attacks are the cause of SLE. Researchers are now identifying the individual genes, the proteins they produce, and their role in the immune system. Each protein is a link on the autoimmune chain, and researchers are trying to find drugs to break each of those links.[3] [6]

SLE is treated by addressing its symptoms by, mainly with cyclophosphamide, corticosteroids and immunosuppressants; there is currently no cure. SLE can be fatal, although with recent medical advances, fatalities are becoming increasingly rare. Survival for people with SLE in the United States, Canada, and Europe is approximately 95% at five years, 90% at 10 years, and 78% at 20 years.[5]

The approach of treating the symptoms exclusively and primarily by utilizing drugs has been the mainstay in medical therapies for years. With the many new findings in stem cell research the autoimmune components of SLE may be reset or adequately modified to modulate this disorder. Some of the newer studies are presented below. The resetting of immune functions is also found in many of the other stem cell treatments of autoimmune diseases, which we encourage you to review.

Autologous Stem-Cell Transplant  Phases :

After a review of your medical records and discussions with medical staff, a protocol is designed especially for you. Specifics of your condition are addressed along with any special needs.  It may be similar to the one illustrated below:

Day 1:

At the clinic you will be examined by our physicians. Information including any risks and expectations concerning your treatment, plus answers to any questions you may have will be addressed.  A blood draw, to determine cell counts and other chemistries will be collected and cell expansion medication may be administered. Then you will return to your hotel for a restful day or a good nights sleep.

Day 2:

At the clinic our physician/s will review the laboratory results, determine if the cell count is within range, and discuss the response to the stimulation. They may or may not provide additional cell expansion medications and may add adjunctive treatments. The levels of your response will determine if you would return to the hotel, with little restriction on your activities, or possibly go forward with harvesting and processing your cells.

Day 3:

If the cell count and viability is appropriate for harvest either a bone marrow or adipose collection will be utilized.  We typically use local anesthetics for adults and general anesthesia for youngsters. The entire procedure normally takes less than 30 minutes. Although some pain is felt when the needle is inserted, most patients do not find the bone marrow or adipose collection procedure particularly painful.

We recently placed a number of videos on our website interviewing our patient’s who discuss the procedure and their lack of discomfort.

After the collection you may return to the hotel, with some restrictions. The bone marrow or adipose collected is processed in our contract State-Of-Art laboratory by trained staff, under the supervision of the lab physician.

As an alternative to the above, cord blood may be used based on the patient’s individual medical condition and options.

Day 4:

At the clinic or at the hospital you will be treated by IV infusion and/or a lumbar puncture, which injects the stem cells into the cerebrospinal fluid. This route transports the cells into the spinal canal and the brain directly influencing the nervous systems, thereby eliminating the brain/blood barrier. If a lumbar puncture is performed, the patient will be required to restrict their activities and potentially spend the day in the hospital or at their hotel.

Day 5:

At the clinic or hospital the patient will receive a post-treatment examination and evaluation prior to their release. Additional therapy and treatments may also be utilized to maximize the placement and activities of the procedure.

Day 6: Optionally there may be the use of additional ancillary therapies to enhance the procedure.

What makes our treatment different ?

Our approach includes stimulation, prior to collection, processing and expansion of the cell along with the use of growth factors, together with an integrated medical approach. This maximizes the growth and implantation potentials yielding optimized potentials of making changes in your disease.

Our staff physicians are all board certified, in their field with years of experience. Your team includes both primary and ancillary care professionals devoted to maximizing your benefits from the procedures. We enroll you in an open registry to track your changes independently, for up to 20 years.

As our patient we also keep you abreast of the newest developments in stem cell research. This is an ongoing relationship to maintain and enhance your health.

Our promise is to provide you with travel and lodging support, access to bilingual staff members throughout the entire process and most importantly the best medical care possible.

References and Articles:

Stem Cells. 2009 Jun;27(6):1421-32. doi: 10.1002/stem.68.

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.

Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that, despite the advances in immunosuppressive medical therapies, remains potentially fatal in some patients, especially in treatment-refractory patients. Here, we reported that impairment of bone marrow mesenchymal stem cells (BMMSCs) and their associated osteoblastic niche deficiency contribute in part to the pathogenesis of SLE-like disease in MRL/lpr mice. Interestingly, allogenic BMMSC transplantation (MSCT) is capable of reconstructing the bone marrow osteoblastic niche and more effectively reverses multiorgan dysfunction when compared with medical immunosuppression with cyclophosphamide (CTX). At the cellular level, MSCT, not CTX treatment, was capable to induce osteoblastic niche reconstruction, possibly contributing to the recovery of regulatory T-cells and reestablishment of the immune homeostasis. On the basis of the promising clinical outcomes in SLE mice, we treated four CTX/glucocorticoid treatment-refractory SLE patients using allogenic MSCT and showed a stable 12-18 months disease remission in all treated patients. The patients benefited an amelioration of disease activity, improvement in serologic markers and renal function. These early evidences suggest that allogenic MSCT may be a feasible and safe salvage therapy in refractory SLE patients.

Stem Cell Infusions Reverse Lupus Complications

Songtao Shi, associate professor at the USC School of Dentistry Published on Mar 19, 2009 Stem Cells

In all of the patients, organ function improved greatly, with two patients lessening their dosages of immunosuppressive drugs to low maintenance levels, and the other two stopping their immunosuppression regimen entirely. Short-term follow-up at 18 months post-mesenchymal stem cells infusion indicated no problems with either organ function or reactions to the transplanted cells, Shi said.

 

“Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms”

Thomas W. Faust, Eric H. Chang, Czeslawa Kowal, RoseAnn Berlin, Irina G. Gazaryan, Eva Bertini, Jie Zhang, Jorge Sanchez-Guerrero, Hilda Fragoso-Loyo, Bruce T. Volpe, Betty Diamond, and Patricio T. HuertaImmunology

Self-generated antibodies could explain neurological symptoms of lupus

Some patients with the autoimmune disorder systemic lupus erythematosus (SLE) suffer neurological symptoms, which range from emotional imbalance and anxiety to cognitive impairment and psychosis. Previous research has tied the onset of neurological symptoms in some patients to high levels of self-generated antibodies against the NMDA receptor (NMDAR)—which is involved in synaptic transmission in the brain—in the patients’ cerebrospinal fluid. To determine how antibodies against the receptor produce neurological symptoms of SLE, Thomas Faust et al. tested the effect of mouse and human antibodies that bind to subunits of the receptor on slices of mouse hippocampus in the laboratory. At low concentration the antibodies activated the receptor, enhancing its synaptic excitatory potential above normal, the authors found. At high concentration the antibodies caused neuronal death by triggering irreversible swelling and collapse of the cells’ mitochondria. Further, the level of NMDAR-reactive antibodies in the cerebrospinal fluid of different patients with SLE corresponded to that required to cause synaptic changes or mitochondrial defects, the authors report. The findings suggest that the level of NMDAR-reactive antibodies and their ability to reach the brain across the blood–brain barrier might determine the severity and duration of the neurological symptoms in patients with SLE, according to the authors.

Comment: We use cognitive testing with many of the autoimmune disease patients and now hav a mechanism to address these unsettling findings.

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Soufiane Ghannam, Carine Bouffi, Farida Djouad, Christian Jorgensen and Danièle Noël

Stem Cell Research & Therapy 2010, 1:2 doi:10.1186/scrt2

Published: 15 March 2010

© 2010 BioMed Central Ltd

Abstract

Mesenchymal stem cells (MSCs) are multipotential nonhematopoietic progenitor cells that are isolated from many adult tissues, in particular from the bone marrow and adipose tissue. Along with their capacity for differentiating into cells of mesodermal lineage, such as adipocytes, osteoblasts and chondrocytes, these cells have also generated great interest for their ability to display immunomodulatory capacities. Indeed, a major breakthrough came with the finding that they are able to induce peripheral tolerance, suggesting they may be used as therapeutic tools in immune-mediated disorders. The present review aims at discussing the current knowledge on the targets and mechanisms of MSC-mediated immunosuppression as well as the potential use of MSCs as modulators of immune responses in a variety of diseases related to alloreactive immunity or autoimmunity.

Conclusion

Overall, the current data indicate that MSCs represent a promising alternative strategy in the treatment of various immune-mediated diseases. Encouraging results have already been obtained from the clinics. Many questions remain to be addressed, however, in order to provide better ways to control and optimize the immune response for the benefit of the patient. This implies a better understanding of the underlying mechanisms of immunosuppression as well as satisfying safety concerns as regards the in vivo survival, formation of ectopic tissue and malignant transformation.

 

Comment: This review article highlights some of the mechanisms and is an excellent piece to consult along with our index of 178 other articles on autoimmune function and stem cell therapy.

.

Share:Share on Facebook4Pin on Pinterest0Tweet about this on Twitter0Share on Google+0Share on LinkedIn0

Testimonials

  • Stem Cell Treatment or Hip Surgery

    Stem Cell Treatment or Hip Surgery

    I have grade IV osteoarthritis (severe loss of cartilage leading to bone rubbing on bone) of my right hip. I have seen 3 orthopedic doctors, all of which have said I need to have surgery for hip replacement. Additional options for treatment were limited. As a nurse, and at my age, having seen both good and bad outcomes following hip replacement, and also knowing hip replacement is not without risk, I chose to seek other options of treatment for myself.

    Read more
  • AUTISM a stem cell treatment success

    AUTISM a stem cell treatment success

    Andrew is thriving. We have seen and continue to see major improvements. He has matured beyond anything I can explain (I have had to rapidly adjust my parenting as I now have a much older & more sophisticated child), his comprehension (perhaps better to say his ability to express and act upon his comprehension) is now age appropriate.

    Read more
  • Hello

    owen_pic

    Hello, When we came from Cancun the first week we noticed an improvement in eye contact. It improved about 70%. His attention improved about 50% and he was more in our world when it comes to understand what it happening around him. He lost some of his attention for the last two weeks but it is still better than it was prior stem cells and even Janik BIs therapist say it is easier to work with Janik in ABA because his eye contact is better and his focus is also better."

    Read more
  • Owen, happy again

    Owen-pic-2

    Well Owen is happy again, which is the biggest improvement. He is laughing and giggling again. His eye contact has improved and he is playing with toys again. All of these things had stopped. I`m so happy that he is happy. ( His Mom)Read more

News

  • Interview with Dr. Ernesto Gutierrez from the World Stem Cells Clinic by Healthcare Elsewhere show with John Cote on iTunes!:

    October 13th, 2014

    October 11, 2014 Dr. Gutierrez is the medical director and president of the World Stem Cells Clinic in Cancun, Mexico. The clinic was established i

     

    Read more

  • Educating Medical Professionals &Patients on Stem Cell Advancements with Dr. Ernesto Gutierrez:

    October 9th, 2014

    Dr. Ernesto Gutierrez, M.D. was interviewed recently for the Healthcare Elsewhere show with John Cote on iTunes! They discussed several things from pa

     

    Read more

  • Doctors Seminars – Stem Cell and Regenerative Medicine Procedures for Orthopedics, Musculoskeletal and Sports Medicine Doctors Training Seminar December 4-5-6th, 2014:

    October 5th, 2014

    Doctors Seminars

    Stem Cell and Regenerative Medicine Procedures for Orthopedics,

     

    Read more

Be sure to visit our Blog!

    • There is a wealth of information available on Stem Cell therapy and the emerging field in general. Many of our patients have asked me to present further information and give them a working knowledge of the terms and general information necessary to understand the industry. Under the Stem Cell Glossery section of our website are some of the most used terms. A posting of additional resources will be present shortly.

      Please note that we will be posting a number of clips for this purpose. In our YouTube area check for the updates. A recent lecture series given at the Annual Gathering of Mensa 2011 will be included.

      Recently a number of clinics have begun selling "cells" for treatments. The treatments are via IV and all sorts of claims are being made. The idea of the franchise of stem cell centers is the opposite of personalized medicine and clearly not the direction that I feel will benefit the majority of patients.

      As a consumer the buyer beware "caveat emptor " needs to be heightened in the competitive environment of questionable practices by "cell" salesman/women.
*DISCLAIMER: As with any medical treatment, no guarantees or claim of cures are made as to the extent of the response to treatment. Results vary from patient to patient, even with a similar diagnosis, as the body's internal status is unique to each individual patient. Because of this fact we cannot offer, infer or suggest that there is any certainty of a given outcome. Many of our treatments are not currently FDA approved. We do not use embryonic or fetal cells in any of our treatments.